| Joseph A Evangelista, MD | |
|
15 Corporate Dr, #2-2, Trumbull, CT 06611-1351 | |
| (203) 268-8673 | |
| Not Available |
| Full Name | Joseph A Evangelista |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 39 Years |
| Location | 15 Corporate Dr, Trumbull, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093711343 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 028306 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
Research conducted at Boston Children's Hospital indicates that obesity might cause asthma via factors in the immune system and suggests a new way of treating asthma in obese people—who often respond poorly to standard asthma medications. The study, conducted in a mouse model of asthma and in human lung fluid, was published online Dec. 15 by Nature Medicine.
In a first-of-its-kind study, Medical College of Georgia researchers are testing whether simulation driving can reduce Parkinson's patients' threefold increased risk of car accidents.
Researchers have found that bowel cancer cells have a mechanism by which they can switch off some key molecules on their surfaces and thus escape being recognised and killed by the immunotherapy agents.
First quarter results reflect challenging revenue picture. Pipeline strengthened by Amgen collaboration, the agreement to acquire Ardea Biosciences and positive CHMP opinion for FORXIGATM (dapagliflozin) in Europe.
› Verified 1 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Research conducted at Boston Children's Hospital indicates that obesity might cause asthma via factors in the immune system and suggests a new way of treating asthma in obese people—who often respond poorly to standard asthma medications. The study, conducted in a mouse model of asthma and in human lung fluid, was published online Dec. 15 by Nature Medicine.
In a first-of-its-kind study, Medical College of Georgia researchers are testing whether simulation driving can reduce Parkinson's patients' threefold increased risk of car accidents.
Researchers have found that bowel cancer cells have a mechanism by which they can switch off some key molecules on their surfaces and thus escape being recognised and killed by the immunotherapy agents.
First quarter results reflect challenging revenue picture. Pipeline strengthened by Amgen collaboration, the agreement to acquire Ardea Biosciences and positive CHMP opinion for FORXIGATM (dapagliflozin) in Europe.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph A Evangelista, MD 226 Mill Hill Ave, 3rd Floor, Bridgeport, CT 06610-2826 Ph: () - | Joseph A Evangelista, MD 15 Corporate Dr, #2-2, Trumbull, CT 06611-1351 Ph: (203) 268-8673 |
News Archive
Research conducted at Boston Children's Hospital indicates that obesity might cause asthma via factors in the immune system and suggests a new way of treating asthma in obese people—who often respond poorly to standard asthma medications. The study, conducted in a mouse model of asthma and in human lung fluid, was published online Dec. 15 by Nature Medicine.
In a first-of-its-kind study, Medical College of Georgia researchers are testing whether simulation driving can reduce Parkinson's patients' threefold increased risk of car accidents.
Researchers have found that bowel cancer cells have a mechanism by which they can switch off some key molecules on their surfaces and thus escape being recognised and killed by the immunotherapy agents.
First quarter results reflect challenging revenue picture. Pipeline strengthened by Amgen collaboration, the agreement to acquire Ardea Biosciences and positive CHMP opinion for FORXIGATM (dapagliflozin) in Europe.
› Verified 1 days ago
Dawn Lukose, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd Ste 220, Trumbull, CT 06611 Phone: 203-374-6162 | |
Geny Ann George, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 Technology Dr Ste 101, Trumbull, CT 06611 Phone: 203-372-7200 | |
Daniel G. Sica, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 888 White Plains Rd, Suite 203, Trumbull, CT 06611 Phone: 203-459-0408 Fax: 203-459-0410 | |
Dr. Molain Saintilus, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd, Suite 220, Trumbull, CT 06611 Phone: 203-374-6162 Fax: 203-374-1549 | |
Linda S Werner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 Technology Dr Unit C101, Trumbull, CT 06611 Phone: 203-372-7200 Fax: 203-374-1473 | |
Dr. William G. Hulcher, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 888 White Plains Rd, Suite 202, Trumbull, CT 06611 Phone: 203-459-9666 Fax: 203-459-9698 |